HUMAN GENOME SCIENCES INC Increase (Decrease) in Deferred Revenue
HUMAN GENOME SCIENCES INC reported Increase (Decrease) in Deferred Revenue of $162.00 thousand for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2012-06-30 was $2.82M, a 99.22% increase year-over-year.
- HUMAN GENOME SCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2012-03-31 was -$2.66M.
- HUMAN GENOME SCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2011-12-31 was $1.79M, a 262.88% increase year-over-year.
- HUMAN GENOME SCIENCES INC increase (decrease) in deferred revenue for the quarter ending 2011-09-30 was $1.85M.
- HUMAN GENOME SCIENCES INC increase (decrease) in deferred revenue for fiscal 2011 was $4.32M.
- HUMAN GENOME SCIENCES INC increase (decrease) in deferred revenue for fiscal 2010 was -$82.89M, a 580.98% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC increase (decrease) in deferred revenue for fiscal 2009 was $17.23M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2012-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $162.00K 10-Q · filed 2012-07-26 | $1.95M derived: sum of 3 quarters · filed 2012-07-26 | $3.80M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | -$2.66M 10-Q · filed 2012-04-26 | -$870.00K derived: sum of 2 quarters · filed 2012-04-26 | $982.00K derived: sum of 3 quarters · filed 2012-04-26 | $2.40M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $3.64M derived: sum of 2 quarters · filed 2012-02-28 | $5.06M derived: sum of 3 quarters · filed 2012-07-26 | $4.32M 10-K · filed 2012-02-28 |
| 2011-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $3.27M derived: sum of 2 quarters · filed 2012-07-26 | $2.53M 10-Q · filed 2011-10-28 | $3.02M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $677.00K 10-Q · filed 2012-07-26 | $1.17M derived: sum of 3 quarters · filed 2012-07-26 | -$35.11M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | -$739.00K 10-Q · filed 2012-04-26 | -$246.00K derived: sum of 2 quarters · filed 2012-04-26 | -$36.53M derived: sum of 3 quarters · filed 2012-04-26 | -$55.84M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$35.79M derived: sum of 2 quarters · filed 2012-02-28 | -$55.10M derived: sum of 3 quarters · filed 2012-02-28 | -$82.89M 10-K · filed 2012-02-28 |
| 2010-09-30 | -$36.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$55.59M derived: sum of 2 quarters · filed 2011-10-28 | -$83.39M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | -$19.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$47.10M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$27.79M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $17.23M 10-K · filed 2012-02-28 |